Alnylam Pharmaceuticals
ALNY
#798
Rank
S$41.05 B
Marketcap
S$306.84
Share price
1.69%
Change (1 day)
-46.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company